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We describe a cluster of cowpox virus (CPXV) infec-
tions in humans that occurred near Munich, Germany, 
around the beginning of 2009. Previously, only sporadic re-
ports of CPXV infections in humans after direct contact with 
various animals had been published. This outbreak involved 
pet rats from the same litter.    
C
owpox virus (CPXV) belongs to the family Poxviridae, 
genus Orthopoxvirus (OPV), and is closely related to 
other species, such as variola virus, vaccinia virus (VV), 
and monkeypox virus. Originally, cows were wrongly pre-
sumed to be CPXV reservoirs. Wild rodents are now con-
sidered to be the true reservoirs; cows, cats, zoo animals, 
and humans are only incidental hosts (1). Human CPXV 
infections are rare and usually cause localized skin lesions. 
However, in immunocompromised patients, severe gener-
alized skin infections may occur (2). CPXV is transmitted 
to humans by direct contact with infected animals, mostly 
cats (3–5). In 2002, Wolfs et al. described a human CPXV 
infection transmitted by a wild rat (6). We report an epi-
demiologically linked cluster of 5 cases of human CPXV 
infection caused by contact with a litter of pet rats (Rattus 
norvegicus).  
The Study
Within 4 days, 5 patients with skin lesions suggestive 
of an OPV infection were reported to the Infectious Dis-
ease Task Force at the Bavarian Health and Food Safety 
Authority. Infected patients were from 2 unrelated families 
living in 2 different counties in the greater Munich area, 
Germany. The families had bought 1 and 2 rats, respective-
ly, from the same pet shop on December 15 and December 
17, 2008. Source tracing showed that the pet shop owner 
had sold a litter of 8 rats to 7 different households in the 
greater Munich area. The pet shop owner had purchased 
the litter from a Bavarian rat breeder 7 days before the last 
rat in the litter was sold. These rats had been kept in cages 
separate from animals of different species. No symptoms 
of OPV infection were reported in the rats or any another 
animal in the pet shop. Moreover, all pet shop workers re-
mained free of signs and symptoms. The breeder denied 
purchasing any animals from abroad that could have been 
related to the 2003 US monkeypox outbreak (7), although 
he did acknowledge owning another breeding facility in the 
Czech Republic. Inspection of the breeding facility in Ba-
varia found 4 rats with crusts suspicious for OPV infection. 
Mice, hamsters, rabbits, and degus (Octodon degus) were 
also bred in the facility, but none had clinical signs of OPV. 
A total of 31 rats from the facility were tested for OPV in-
fection by oral swabs and serology. 
Members of 6 households were interviewed; 1 cus-
tomer gave a wrong address. According to their owners, 
all pet rats were asymptomatic when purchased, but 2 rats 
(1 in each family with a human OPV infection) died after 9 
and 14 days, respectively. One rat had distinct skin lesions 
on its extremities, mouth, and nose (Figure 1, panel A); the 
other had only 2 very small lesions on its front leg and nose. 
Two additional rats from the litter in 2 other households 
were euthanized due to clinical suspicion of OPV infection; 
3 rats were assessed as healthy by their owners.
In households 1 and 2 (Table) with human cases of 
infection, 2 and 3 persons, respectively, reported only di-
rect skin contact with their pet rats since the ﬁ  rst day of 
purchase. All patients had circumscribed nodules with 
central necrosis and inﬂ  amed edges. Skin lesions were up 
to 1.5 cm in diameter. Notably, the onset and severity of 
symptoms were apparently associated with a patient’s VV 
vaccination status: 2 girls (patients 2 and 5, each 16 years 
of age with no history of VV vaccination) had multiple 
lesions on the neck, chest, and abdomen (Figure 1, panel 
B) accompanied by fever and local lymphadenopathy. In-
cubation periods for these 2 patients were 3 and 5 days, 
respectively. In contrast, the incubation period for 2 VV-
vaccinated mothers (patients 1 and 3, 42 and 40 years of 
age, respectively) and for the VV-vaccinated grandmother 
of 1 of the girls (patient 4, 60 years of age) was >7 days. All 
showed less severe symptoms (Figure 1, panel C) without 
fever or lymphadenopathy and only 1 small skin lesion on 
the neck or chest.
In household 3, one person was receiving cyclosporine 
therapy after a kidney transplantation. She already owned 
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ter. After 35 days, skin lesions developed in all of her rats, 
including the initially asymptomatic index rat. All were eu-
thanized due to clinical suspicion of OPV.  Fortunately, the 
kidney transplant patient without previous VV vaccination 
did not develop signs or symptoms suggestive of CPXV 
infection. Nevertheless, we collected a blood sample and 
swabs from her throat and a recent rat-bite ﬁ  nger wound.
Various specimens (skin biopsies, crusts, oral swabs, 
serum, and whole blood) obtained from 5 patients and 
from rats from 3 households and 31 other rats (9–39) 
from the local breeding facility in Bavaria were sent to 
the Bavarian Health and Food Safety Authority (Table). 
Depending on specimen type, various investigations were 
performed (Table). Skin biopsy and crust specimens were 
homogenized and inspected for typical OPV-like particles 
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Figure 1. Figure 1. Cowpox lesions on rats and humans during an outbreak in Germany, 2009. A) Rat named Shiva (strain named after 
this rat) with lesions on the right hind limb; it died 1 day later. B) Neck lesions of a girl without previous vaccinia virus (VV) vaccination. C) 
Neck lesion of the girl’s grandmother with a history of VV vaccination. Photographs taken by authors 13 days after purchase of the rats. 
Patient is the grandmother (patient no. 4); rat is rat no. 2. 
Table. Summary of investigations for cowpox virus, by source, household, and individual (human or rat), Munich, Germany, 2009* 
Diagnostic methods
Pet origins, households, 
and cases  Clinical findings  Specimens Antibody titer EM†  PCR† Sequencing
Virus
isolation
Pet shop
Household 1
    Human case 1  Lesion Skin biopsy, 
serum 
640 ND Positive Cowpox virus Positive 
    Human case 2  Multiple lesions  Serum 2,560 ND ND ND ND
    Rat 1  Lesions, fatal outcome  Crusts ND ND Positive Cowpox virus ND
Household 2
  Human  case  3  Lesion Crust ND ND Positive Cowpox  virus Positive 
    Human case 4  Lesion  NA  ND ND ND ND ND
    Human case 5  Multiple lesions  Crust, serum  1,280 Positive Positive Cowpox virus Positive 
    Rat 2 and 3  Rat 2: lesion, fatal 
outcome; rat 3: healthy 
(no symptoms) 
Crusts, serum  Rat 2: 1,280  Rat 2 
positive
Rat 2 
positive
Rat 2, 
cowpox virus
Rat 2 
positive
Household 3
  Human  contact  None Swabs,  blood, 
serum 
Negative ND Positive ND ND
    Rat 4 plus 4  
  previously  owned   
  rats  (40–43) 
All rats: lesions, 
euthanized
Crusts 3/3 positive: 
160, 1,280, 
2,560
ND 5/5
positive
Cowpox virus ND
Households 4–6 
  Human  contacts   
  +  rats  5–7 
All rats and human 
contacts with no clinical 
findings; 2 rats 
euthanized
NA ND ND ND ND ND
Breeder
  Rats 9–39  4 rats with lesions (1 
dead); all others with 
no clinical findings 
Mouth swabs, 
serum 
4/30 positive 
(>40)
ND 17/31
positive
Cowpox virus ND
*All obtained hemagglutinin open reading frames were 924 bp, and the respective sequences were 100% identical to each other (GenBank accession no. 
FJ654467). Rat 8 from the outbreak litter belonging to household 7 is missing because the rat owner could not be identified. EM, electron microscopy; 
ND, not done; NA, materials not available. 
†For Orthopoxvirus spp. Cowpox Virus from Pet Rats to Humans
by using electron microscopy. Virus isolation for these 
materials was performed using standard procedures. DNA 
from all samples was extracted using the QIAamp DNA 
Mini Kit (QIAGEN, Hilden, Germany) according to the 
manufacturer’s instructions. For OPV DNA detection, 
the RealArt Orthopoxvirus LC Kit (QIAGEN) was used. 
For species identiﬁ  cation, the products of a second PCR, 
spanning the entire open reading frame of the hemaggluti-
nin gene (8,9), were sequenced. Datasets were edited and 
aligned using BioEdit (10). BLAST search (www.ncbi.
nlm.nih.gov/blast/Blast.cgi) was performed to conﬁ  rm 
species identiﬁ  cation of the isolated strain as well as simi-
larity with published CPXV strains. A phylogenetic tree 
was constructed using the maximum parsimony method 
with the Phylogeny Inference Package version 3.68 
(http://evolution.genetics.washington.edu/phylip.html) 
with 100 bootstraps; the tree was drawn with TreeView 
version 1.6.6 (http://taxonomy.zoology.gla.ac.uk/rod/
treeview.html) (Figure 2). OPV-speciﬁ  c serum antibody 
titers were determined using an immunﬂ  uorescence test 
based on VV-infected cells and either an antihuman or an 
antirat immunoglobulin G ﬂ  uorescein-labeled conjugate 
(Dako, Hamburg, Germany). 
Conclusions
Besides molecularly proven wild rat-to-human CPXV 
transmission (6) an additional CPXV infection probably 
transmitted from a pet rat was reported (11). Recently, 4 
human infections acquired from pet rats were reported to 
the reference laboratory for poxviruses at the Robert Koch 
Institute (12). We describe a CPXV outbreak among 5 
patients caused by infected pet rats from the same litter. 
CPXV infections seem to be increasing (13), but because 
CPXV infections in humans and in most animals (e.g., cats) 
are not notiﬁ  able, this increase remains an assumption. One 
obvious reason for an increase might be the fading cross-
protective immunity to OPV after the cessation of VV vac-
cination (14). In our small cluster, the onset and severity 
of symptoms seemed to be correlated with VV vaccination 
status; however, although patients reported similar contact 
with pet rats, patient age and manner of infection might 
confound this hypothesis (15).
The rising popularity of pet rats might also be a point 
of concern in a population with decreasing cross-protection 
to OPV and an increasing number of immunocompromised 
persons.    Our ﬁ  ndings emphasize the necessity to monitor 
OPV infections in humans and all animals (e.g., notiﬁ  ca-
tion requirement) and to improve public awareness. Our 
outbreak investigation underlines the importance of close 
cooperation between human health and veterinary authori-
ties in the management of zoonotic diseases.   
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Figure 2. Phylogenetic tree of the isolated cowpox virus (CPXV) 
Shiva strain (in boldface; named after pet rat shown in Figure 1, 
panel A; GenBank accession no. FJ654467), constructed by the 
maximum-parsimony method based on the partial sequences 
method based on the hemagglutinin (HA) gene, unrooted. BLAST 
search (www.ncbi.nlm.nih.gov/blast/Blast.cgi) conﬁ  rmed  the 
identiﬁ   cation of this strain as a CPXV strain with a unique HA 
gene sequence. The highest identity of 98.1% was found for strain 
cowHA72 (accession no. AY902300), a CPXV strain isolated from 
an elephant in the Netherlands. Bootstrap values >50% are shown. 
Additional unique CPXV strains shown for comparison, by accession 
number: AY902307 (cowHA35e), AY902301 (cowHA82), AY902299 
(cowHA70), AY902298 (cowHA68), AY902297 (cowHA52), 
AY902296 (cowHA51), AY902295 (cowHA48), AY902294 
(cowHA46), AY902289 (cowHA47), AY902288 (cowHA41), 
AY902287 (cowHA40), AY902286 (cowHA37), AY902279 
(cowHA76), AY902276 (cowHA23), AY902308 (cowHA38), 
AY902275 (cowHA22), AY902274 (cowHA21), AY902273 
(cowHA81), AY902271 (cowHA19), AY902270 (cowHA18), 
AY902269 (cowHA17), AY902268 (cowHA16), AY902263 
(cowHA15), AY902262 (cowHA34), AY902260 (cowHA13), 
AY902257 (cowHA09), AY902256 (cowHA07), AY902255 
(cowHA63), AY902252 (cowHA73), AY944029 (CPV90_ger2), 
AY944028 (CPV91_ger3), AF377886 (cowpox virus), AF377885 
(cpv-922-99), AF377884 (cpv-867-99b), AF377883 (cpv-667-94b), 
AF377877 (cpv-1218-00), AF375090 (cpx-ep-2), AF375089 (cpx-
brt), AF375088 (cpx-90-5), AF375087 (CPX-90-1), AF375086 (cpx-
89-5), AF375085 (cpx-89-4), and AF375084 (cpx-89-1). and Philipp Kayßer for constructive support during the outbreak 
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